E.G. Brown Jr, D.S. Dooley, K. SmithCurry International Tuberculosis Center, State of California, California Health & Human Service Agency, Department of Public Health
(2016)
C1
5th revised edition.
This document provides a ranking of medically important antimicrobials for risk management of antimicrobial resistance due to non-human use. The current revision took place at the seventh meeting of the AGISAR held in Raleigh, United States of America in 2016.